Skip to main content
. 2020 Dec 17;8(1):ofaa607. doi: 10.1093/ofid/ofaa607

Table 1.

Agreement Between RT-PCR and ID Now (95% CI) in Symptomatic and Asymptomatic Patients

Site Bed Size Total Samples Tested ID Now-/PCR+ ID Now-/PCR- ID Now+/No PCR ID Now+/PCR- ID Now Positive Rate, % False Negative Rate Negative Agreement (NPV) Sensitivity Performance Agreement (Fleiss Kappa)
Symptomatic
1 548 394 9 (6a–3b) 352 (258a–94b) 33 0 8.61 21.43 (10.30–36.81) 97.51 (95.32–98.85) 78.57 (63.19–89.70) 0.855 (0.757–0.953)
2 497 341 8 292 41 0 12.02 16.33 (7.32–29.66) 97.33 (94.81–98.84) 83.67 (70.34–92.68) 0.898 (0.792–1.003)
3 304 743 22 524 197 0 26.51 10.05 (6.40–14.81) 95.97 (93.96–97.46) 89.95 (85.19–93.60) 0.927 (0.855–0.998)
4 66 57 0 54 3 0 5.26 0.00 (0.00–70.76) 100.00 (93.40–100.00) 100.00 (29.24–100.00) 1 (0.74–1.26)
5 133 34 0 33 1 0 2.94 0.00 (0.00–97.50) 100.00 (89.42–100.00) 100.00 (2.50–100.00) 1 (0.664–1.336)
Total
All 1547 1569 39 1255 275 0 17.58 12.42 (8.98–16.59) 96.99 (95.90–97.85) 87.58 (83.41–91.02) 0.917 (0.867–0.966)
Asymptomatic
1 548 386 3 383 0 0 99.22 (97.75–99.84)

Abbreviations: PCR, polymerase chain reaction; NPV, negative predictive value; RT-PCR, reverse transcription polymerase chain reaction.

aAbbott m2000.

bCepheid GeneXpert.